Assessment of atrial overdrive pacing as a treatment for OSAHS. (A prospective, randomized crossover study)
S. E. Schiza, E. N. Simantirakis, S. I. Chrysostomakis, N. C. Klapsinos, P. E. Vardas, N. M. Siafakas (Heraklion, Greece)
Source: Annual Congress 2005 - Clinical aspects of OSA II
Session: Clinical aspects of OSA II
Session type: Thematic Poster Session
Number: 3627
Disease area: Respiratory critical care, Sleep and breathing disorders
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. E. Schiza, E. N. Simantirakis, S. I. Chrysostomakis, N. C. Klapsinos, P. E. Vardas, N. M. Siafakas (Heraklion, Greece). Assessment of atrial overdrive pacing as a treatment for OSAHS. (A prospective, randomized crossover study). Eur Respir J 2005; 26: Suppl. 49, 3627
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Evaluating flutter device and the active cycle of breathing technique in non-cystic bronchiectasis: The prospective randomised study Source: Annual Congress 2012 - Management of severe respiratory infections Year: 2012
BAY 2253651 for the treatment of obstructive sleep apnoea: a multicentre, double-blind, randomised controlled trial (SANDMAN) Source: Eur Respir J, 58 (5) 2101937; 10.1183/13993003.01937-2021 Year: 2021
Glycopyrronium does not affect QT interval in healthy subjects: A randomized, 3-period cross-over, placebo- and positive-controlled study Source: Annual Congress 2013 –LAMA, LABA, ICS and their combinations for the treatment of asthma and COPD Year: 2013
Effects of continuous positive airway pressure therapy on left ventricular diastolic function: a randomised, sham-controlled clinical trial Source: Eur Respir J, 51 (2) 1701774; 10.1183/13993003.01774-2017 Year: 2018
Quality of life in patients with COPD and nocturnal supplemental oxygen-therapy: a prospective, placebo-controlled cross-over trial Source: Eur Respir J 2005; 26: Suppl. 49, 289s Year: 2005
Reduced lung function and risk of atrial fibrillation in a prospective cohort study Source: Eur Respir J 2002; 20: Suppl. 38, 401s Year: 2002
A randomised, double-blind, crossover, placebo-controlled trial of a mandibular advancement device for the treatment of snoring and mild obstructive sleep apnoea-hypopnoea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 102s Year: 2002
Effect of breathing oxygen-enriched air on exercise performance in patients with pulmonary hypertension in heart failure with preserved ejection fraction. Randomized, placebo-controlled, cross-over trial. Source: Virtual Congress 2021 – Non-pulmonary arterial hypertension pulmonary hypertension Year: 2021
A feasibility, randomised controlled trial of a complex breathlessness intervention in idiopathic pulmonary fibrosis (BREEZE-IPF): study protocol Source: ERJ Open Res, 5 (4) 00186-2019; 10.1183/23120541.00186-2019 Year: 2019
Effectiveness of non-invasive ventilation in stable chronic obstructive pulmonary disease with nocturnal desaturation: Prospective open-label randomized parallel-group study Source: Annual Congress 2013 –Long-term NIV: COPD, sleep, obesity and outcomes Year: 2013
Effects of ghrelin on the dyspnea pattern in cachectic COPD: Exploratory analysis of a substudy of a multicenter, randomized, double-blind, placebo-controlled trial of ghrelin treatment Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation Year: 2013
Early diaphragm pacing to delay non-invasive ventilation in patients with amyotrophic lateral sclerosis (RespiStimALS): A multicenter, triple-blind, randomized controlled trial Source: International Congress 2016 – Best abstracts in pulmonary rehabilitation and chronic care Year: 2016
Auto-servoventilation in heart failure with sleep apnoea: a randomised controlled trial Source: Eur Respir J 2013; 42: 1244-1254 Year: 2013
Diaphragmatic breathing training in COPD patients: A randomized, controlled and blinded trial Source: Annual Congress 2010 - Respiratory muscles and breathing: assessment and training Year: 2010
LATE-BREAKING ABSTRACT: COPD-associated severe pulmonary hypertension (COPDPH): results of a 16-weeks prospective multicenter, double-blind, placebo-controlled randomized clinical trial (RCT) [SPHERIC-1 (http://clinicaltrials.gov/ct2/show/NCT01441934)] investigating the effect of sildenafil citrate (Sld) on pulmonary vascular resistance (PVR) and PaO2. Source: Annual Congress 2013 –Pulmonary circulation: basic science Year: 2013
Oxygen uptake during cycle ergometry with and without functional electrical stimulation in COPD patients: a randomised placebo-controlled cross-over trial Source: International Congress 2017 – Exercise training and breathing exercises in chronic respiratory disease Year: 2017
Mandibular advancement device versus continuous positive airway pressure for treatment of obstruvtive sleep apnea syndrome: a randomized crossover trial Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea Year: 2007
A prospective, randomised, cross-over study comparing unattended home-based versus attended in-hospital polysomnography Source: Annual Congress 2009 - Diagnostic aspects in obstructive sleep apnoea Year: 2009
Acetazolamide administration following upper airway surgery for SDB. Preliminary results of a randomized, double-blind, placebo-controlled study Source: Eur Respir J 2005; 26: Suppl. 49, 201s Year: 2005
Effects of suboptimal adherence of CPAP therapy on symptoms of obstructive sleep apnoea: a randomised, double-blind, controlled trial Source: Eur Respir J, 55 (3) 1901526; 10.1183/13993003.01526-2019 Year: 2020